Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

390315

	registered interest
	date	15/07/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Parkinson's Disease: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what research his Department has (a) commissioned and (b) conducted on Parkinson's disease in the last five years.
	tabling member constituency	Huddersfield
	tabling member printed	Mr Barry Sheerman
	uin	7492
	answer	answer is ministerial correction date of answer 22/07/2015 answer text <p>The Department’s National Institute for Health Research (NIHR) funds a wide range of research relating to Parkinson’s disease through its programmes, fellowship schemes, research centres and units, clinical research facilities and the NIHR Clinical Research Network.</p><p> </p><p> </p><p> </p><p>Major investments that relate fully or partially to Parkinson’s disease include:</p><p> </p><p> </p><p> </p><p>- £3.5 million for the research theme on dementia and neurodegenerative disease at the NIHR Cambridge Biomedical Research Centre (2012-17);</p><p> </p><p>- £3.1 million for the research theme on neuroscience at the NIHR Imperial Biomedical Research Centre (2012-17);</p><p> </p><p>- £3.0 million for the research theme on functional neuroscience and imaging at the NIHR Oxford Biomedical Research Centre (2012-17);</p><p> </p><p>- £2.0 million for a programme of research to inform clinical management of visual hallucinations associated with Parkinson’s disease and other conditions (2012-18);</p><p> </p><p>- £1.9 million for a trial of the effectiveness of an intervention to prevent falls among people with Parkinson’s disease (2013-17); and</p><p> </p><p>- £1.3 million for an evaluation of short-term integrated palliative care services to optimise care for people with advanced long-term neurological conditions (2014-18).</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 22/07/2015 14:36:07 answering member 4020 label Biography information for George Freeman
	tabling member	411 label Biography information for Mr Barry Sheerman

390323

	registered interest
	date	15/07/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Allergies: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what research his Department has commissioned or conducted on allergic diseases.
	tabling member constituency	Huddersfield
	tabling member printed	Mr Barry Sheerman
	uin	7454
	answer	answer is ministerial correction date of answer 22/07/2015 answer text <p>The Department’s National Institute for Health Research (NIHR) funds a wide range of research relating to allergic diseases through its programmes, fellowship schemes, research centres and units, clinical research facilities and the NIHR Clinical Research Network.</p><p> </p><p> </p><p> </p><p>Major current investments include:</p><p> </p><p>- £2.5 million for the South Manchester respiratory and allergy clinical research facility;</p><p> </p><p>- £2.2 million for the research theme on environment, respiratory health and allergy at the biomedical research centre at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London;</p><p> </p><p>- £1.9 million for a trial to determine whether skin barrier enhancement with emollients can prevent eczema in high risk children;</p><p> </p><p>- £1.4 million for a trial of a behavioural change package to prevent hand dermatitis in nurses working in the NHS; and</p><p> </p><p>- £1.3 million for a trial of the effectiveness of the nocturnal use of a temperature controlled laminar airflow device in adults with poorly-controlled, severe allergic asthma.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 22/07/2015 15:58:47 answering member 4020 label Biography information for George Freeman
	tabling member	411 label Biography information for Mr Barry Sheerman

449870

	registered interest
	date	02/02/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	NHS: WiFi
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what risk assessment he has conducted on the proposed rollout of wifi in NHS buildings.
	tabling member constituency	Huddersfield
	tabling member printed	Mr Barry Sheerman
	uin	25314
	answer	answer is ministerial correction date of answer 09/02/2016 answer text <p>Free wi-fi throughout National Health Service premises is an independent recommendation from Baroness Lane Fox to the National Information Board.</p><p> </p><p>As part of the implementation of Baroness Lane Fox’s recommendations, NHS England will be carrying out a more comprehensive review of current provision, benefits and barriers to wi-fi throughout the NHS estate. This will include assessment of any risks.</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 09/02/2016 14:43:29 answering member 4020 label Biography information for George Freeman
	tabling member	411 label Biography information for Mr Barry Sheerman

222588

	registered interest
	date	20/02/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Antimicrobials: Drug Resistance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent research his Department has conducted, funded or commissioned into the transmission of antimicrobial resistance from animal pathogens to human pathogens.
	tabling member constituency	Huddersfield
	tabling member printed	Mr Barry Sheerman
	uin	224785
	answer	answer is ministerial correction date of answer 27/02/2015 answer text <p>Public Health England (PHE), the Veterinary Medicines Directorate and colleagues from the devolved administrations plan to publish a joint report (One Health Report 2015) on human and animal antibiotic use and resistance in the United Kingdom in May 2015. The report compares primary/secondary care prescribing data and veterinary antibiotic sales data and presents antimicrobial resistance (AMR) levels to key antibiotics used in human and veterinary medicine for important indicator (<em>Escherichia coli</em>) and zoonotic (<em>Campylobacter</em> spp., non-typhoidal <em>Salmonella</em>) bacteria. There are significant differences in the surveillance systems providing the data for this report; this report will improve the understanding of the AMR relationship between animals and humans in the UK.</p><p> </p><p> </p><p> </p><p>PHE is being funded by the Department’s Policy Research Programme and the Food Standards Agency to look at public health risk associated with extended-spectrum beta-lactamase (ESBL) positive <em>E. Coli</em> from non-human reservoirs. This will be the largest study of its kind undertaken in the UK and involves England, Wales and Scotland. It is planned to publish the report in 2016.</p><p> </p><p> </p><p> </p><p>The Department’s National Institute for Health Research is funding a Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford. This is a research partnership between the university and PHE. The unit is working with the Animal and Plant Health Agency to develop and validate tools to look for resistance genes in bacteria from diverse sources using new genome sequencing technologies rather than classical methods.</p><p> </p><p> </p><p> </p><p>A study by researchers at the former Health Protection Agency, published in 2010, investigated <em>E. coli</em> producing ESBL enzymes from chicken meat imported into the UK from South America. The study specifically looked at whether the meat was a source of the common ST131 clone or CTX-M 15 ESBL producers. It was concluded that this was not a significant source of either the ST131 clone or the CTX-M 15 ESBLs in the UK. The publication is available at:</p><p> </p><p> </p><p> </p><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/20889530" target="_blank">http://www.ncbi.nlm.nih.gov/pubmed/20889530</a></p><p> </p><p> </p><p> </p><p>Work funded by the Medical Research Council includes research led by the University of Cambridge looking at emergence of methicillin-resistant staphylococcus aureus in cattle and transmission to humans.</p><p> </p><p> </p><p> </p><p>The Antimicrobial Resistance Funders’ Forum (AMRFF) has been established to provide a forum for the sharing of information on activities relating to AMR, and in particular anti-bacterial resistance, by the various member organisations. The Forum provides a framework for a more coordinated approach to tackling AMR research to maximise impact on national and international policies and activities. Membership of the AMRFF includes the Research Councils, Health Departments, Governmental bodies as well as charities with a direct or indirect interest in AMR and which provide significant research and development budgets in the area.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 224784 question first answered 27/02/2015 12:18:59 answering member 4020 label Biography information for George Freeman
	tabling member	411 label Biography information for Mr Barry Sheerman

222483

	registered interest
	date	20/02/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Antimicrobials: Drug Resistance
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what recent research his Department has conducted, funded or commissioned into the transmission of antimicrobial resistance from animal pathogens to human pathogens.
	tabling member constituency	Huddersfield
	tabling member printed	Mr Barry Sheerman
	uin	224784
	answer	answer is ministerial correction date of answer 27/02/2015 answer text <p>Public Health England (PHE), the Veterinary Medicines Directorate and colleagues from the devolved administrations plan to publish a joint report (One Health Report 2015) on human and animal antibiotic use and resistance in the United Kingdom in May 2015. The report compares primary/secondary care prescribing data and veterinary antibiotic sales data and presents antimicrobial resistance (AMR) levels to key antibiotics used in human and veterinary medicine for important indicator (<em>Escherichia coli</em>) and zoonotic (<em>Campylobacter</em> spp., non-typhoidal <em>Salmonella</em>) bacteria. There are significant differences in the surveillance systems providing the data for this report; this report will improve the understanding of the AMR relationship between animals and humans in the UK.</p><p> </p><p> </p><p> </p><p>PHE is being funded by the Department’s Policy Research Programme and the Food Standards Agency to look at public health risk associated with extended-spectrum beta-lactamase (ESBL) positive <em>E. Coli</em> from non-human reservoirs. This will be the largest study of its kind undertaken in the UK and involves England, Wales and Scotland. It is planned to publish the report in 2016.</p><p> </p><p> </p><p> </p><p>The Department’s National Institute for Health Research is funding a Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford. This is a research partnership between the university and PHE. The unit is working with the Animal and Plant Health Agency to develop and validate tools to look for resistance genes in bacteria from diverse sources using new genome sequencing technologies rather than classical methods.</p><p> </p><p> </p><p> </p><p>A study by researchers at the former Health Protection Agency, published in 2010, investigated <em>E. coli</em> producing ESBL enzymes from chicken meat imported into the UK from South America. The study specifically looked at whether the meat was a source of the common ST131 clone or CTX-M 15 ESBL producers. It was concluded that this was not a significant source of either the ST131 clone or the CTX-M 15 ESBLs in the UK. The publication is available at:</p><p> </p><p> </p><p> </p><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/20889530" target="_blank">http://www.ncbi.nlm.nih.gov/pubmed/20889530</a></p><p> </p><p> </p><p> </p><p>Work funded by the Medical Research Council includes research led by the University of Cambridge looking at emergence of methicillin-resistant staphylococcus aureus in cattle and transmission to humans.</p><p> </p><p> </p><p> </p><p>The Antimicrobial Resistance Funders’ Forum (AMRFF) has been established to provide a forum for the sharing of information on activities relating to AMR, and in particular anti-bacterial resistance, by the various member organisations. The Forum provides a framework for a more coordinated approach to tackling AMR research to maximise impact on national and international policies and activities. Membership of the AMRFF includes the Research Councils, Health Departments, Governmental bodies as well as charities with a direct or indirect interest in AMR and which provide significant research and development budgets in the area.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman grouped question UIN 224785 question first answered 27/02/2015 12:18:58 answering member 4020 label Biography information for George Freeman
	tabling member	411 label Biography information for Mr Barry Sheerman

171823

	registered interest
	date	02/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the Minister for Life Sciences' announcement on 20 November 2014 on considering how to speed-up patient access to medicines, devices and diagnostics, what discussions his Department has had with (a) NICE and (b) NHS England on that matter.
	tabling member constituency	Huddersfield
	tabling member printed	Mr Barry Sheerman
	uin	219612
	answer	answer is ministerial correction date of answer 09/01/2015 answer text <p>The review of the pathways for the development, assessment, and adoption of innovative medicines and medical technology will consider how to speed up access for National Health Service patients to cost-effective new diagnostics, medicines and devices. Officials have already had preliminary discussions with both the National Institute for Health and Care Excellence and NHS England, and these will continue as the review progresses.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 09/01/2015 14:34:15 answering member 4020 label Biography information for George Freeman
	tabling member	411 label Biography information for Mr Barry Sheerman

171827

	registered interest
	date	02/01/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Drugs: Scotland
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the announcement made by the Scottish Cabinet Secretary for Health and Wellbeing on 7 October 2014, if he will introduce a scheme similar to the New Medicines Fund in England.
	tabling member constituency	Huddersfield
	tabling member printed	Mr Barry Sheerman
	uin	219610
	answer	answer is ministerial correction date of answer 09/01/2015 answer text <p>The Government has no plans to do so.</p><p> </p><p><strong> </strong></p><p> </p><p>In August 2014, we announced an additional £160 million for the Cancer Drugs Fund. This increases the budget of the Cancer Drugs Fund from £200 million to £280 million in 2014-15 and 2015-16.</p><p> </p><p><strong> </strong></p><p> </p><p>The Government is implementing all of the commitments in the 2014 Pharmaceutical Price Regulation Scheme (PPRS) on improving access to innovative medicines commensurate with the outcomes they offer patients. In addition, NHS England and the Association of the British Pharmaceutical Industry are pressing ahead with plans to maximise the benefits of the PPRS by improving access to and optimising the use of medicines to improve patient outcomes.</p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 09/01/2015 14:37:49 answering member 4020 label Biography information for George Freeman
	tabling member	411 label Biography information for Mr Barry Sheerman